AVB vs RNA · P/E 23, rev $3.04B vs rev $22.6M
AvalonBay Communities Inc (AVB) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. RNA currently screens at market cap $217.5M.
Not investment advice. Open the AVB and RNA stock pages for the full models.
Not investment advice.